Kentavious Caldwell-Pope to ORL

Jul 6, 20242024-25free agent signingplayer page →transaction →

Listed top needs: shooting, rebounding, screening.

Strongest prior functions: event creation, shooting, rebounding.

Stable front-end label for the underlying evidence state; inspect the supporting relation for the measured fields and evidence boundary.

Matched needs: rebounding, shooting. Match ratio 67%.

The incoming player's strongest observed functions matched one or more of the receiving team's leading pre-move needs.

Post-move strongest functions: event creation, screening, shooting. Realized overlap 67%.

Some of the player's strongest prior functions appeared after the acquisition, while others did not.

No outgoing assets recorded

Stable front-end label for the underlying evidence state; inspect the supporting relation for the measured fields and evidence boundary.

Selected player charge $22.8M — 16.2% of the cap

Lead executive: Jeff Weltman. regime page →

The decision date falls inside one resolved basketball-authority regime for this team.

{"team":"ORL","build_id":"authority_regime_portfolio_lineup_context_portability_resilience_v1_20260823","plain_label":"Abstain No Retained Provider Baseline","recorded_at":"2026-08-23T21:07:03.826928+00:00","available_at":"2026-08-23T21:07:03.826927+00:00","franchise_id":52,"decision_date":"2024-07-

{"team":"ORL","build_id":"authority_regime_portfolio_lineup_context_portability_resilience_v1_20260823","plain_label":"Abstain No Retained Provider Baseline","recorded_at":"2026-08-23T21:07:03.826976+00:00","available_at":"2026-08-23T21:07:03.826975+00:00","franchise_id":52,"decision_date":"2024-07-

{"team":"ORL","build_id":"authority_regime_portfolio_lineup_context_portability_resilience_v1_20260823","plain_label":"Abstain No Retained Provider Baseline","recorded_at":"2026-08-23T21:07:03.827024+00:00","available_at":"2026-08-23T21:07:03.827023+00:00","franchise_id":52,"decision_date":"2024-07-

{"team":"ORL","build_id":"authority_regime_portfolio_lineup_function_interaction_v1_20260822","plain_label":"Abstain No Retained Provider Baseline","recorded_at":"2026-08-23T05:21:15.726073+00:00","available_at":"2026-08-23T05:21:39.125465+00:00","franchise_id":52,"decision_date":"2024-07-06","funct

{"team":"ORL","build_id":"authority_regime_portfolio_lineup_function_interaction_v1_20260822","plain_label":"Abstain No Retained Provider Baseline","recorded_at":"2026-08-23T05:21:15.726073+00:00","available_at":"2026-08-23T05:21:39.125492+00:00","franchise_id":52,"decision_date":"2024-07-06","funct

{"team":"ORL","build_id":"authority_regime_portfolio_lineup_function_interaction_v1_20260822","plain_label":"Abstain No Retained Provider Baseline","recorded_at":"2026-08-23T05:21:15.726073+00:00","available_at":"2026-08-23T05:21:39.125509+00:00","franchise_id":52,"decision_date":"2024-07-06","funct

{"team":"ORL","build_id":"authority_regime_portfolio_function_workload_transfer_v1_20260822","plain_label":"No Retained Provider Baseline","recorded_at":"2026-08-23T02:46:37.43008+00:00","available_at":"2026-08-23T02:46:37.43008+00:00","franchise_id":52,"decision_date":"2024-07-06","function_code":"